• Home

  • Documents

  • vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50...
7

vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50 IU/ml, y-GT 1.3 IU/I ve serüloplazmin konsantrasyonu 10.8 mg/dl sap- tandl. Hasta Olan

Embed Size (px)

Citation preview

Page 1: vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50 IU/ml, y-GT 1.3 IU/I ve serüloplazmin konsantrasyonu 10.8 mg/dl sap- tandl. Hasta Olan
Page 2: vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50 IU/ml, y-GT 1.3 IU/I ve serüloplazmin konsantrasyonu 10.8 mg/dl sap- tandl. Hasta Olan
Page 3: vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50 IU/ml, y-GT 1.3 IU/I ve serüloplazmin konsantrasyonu 10.8 mg/dl sap- tandl. Hasta Olan
Page 4: vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50 IU/ml, y-GT 1.3 IU/I ve serüloplazmin konsantrasyonu 10.8 mg/dl sap- tandl. Hasta Olan
Page 5: vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50 IU/ml, y-GT 1.3 IU/I ve serüloplazmin konsantrasyonu 10.8 mg/dl sap- tandl. Hasta Olan
Page 6: vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50 IU/ml, y-GT 1.3 IU/I ve serüloplazmin konsantrasyonu 10.8 mg/dl sap- tandl. Hasta Olan
Page 7: vetjournal.istanbul.edu.trvetjournal.istanbul.edu.tr/archive/1983-2/3.pdf · 69 IU/ml, GPT 50 IU/ml, y-GT 1.3 IU/I ve serüloplazmin konsantrasyonu 10.8 mg/dl sap- tandl. Hasta Olan

The immune microenvironment in cutaneous … · broth supplemented with 20% fetal bovine serum, 100 IU/mL of penicillin and 100 IU/mL of streptomycin (Sigma, St. Louis, MO, USA)

The immune microenvironment in cutaneous … · broth supplemented with 20% fetal bovine serum, 100 IU/mL of penicillin and 100 IU/mL of streptomycin (Sigma, St. Louis, MO, USA)

Documents
British Working Standard for HBsAg 0.2IU/ml · This material contains 0.2 IU/ml HBsAg subtype ad. It has been calibrated against the 1st International standard for HBsAg (NIBSC Code

British Working Standard for HBsAg 0.2IU/ml · This material contains 0.2 IU/ml HBsAg subtype ad. It has been calibrated against the 1st International standard for HBsAg (NIBSC Code

Documents
Viral Vector Analytical Paradigms, Platforms and …€¢ Infectivity = Report Results (IU/mL) • Particle:Infectivity ratio = < X vg/IU* *P: ... 5.6e5 pg per mL / 0.07519 pg genomic

Viral Vector Analytical Paradigms, Platforms and …€¢ Infectivity = Report Results (IU/mL) • Particle:Infectivity ratio = < X vg/IU* *P: ... 5.6e5 pg per mL / 0.07519 pg genomic

Documents
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS...Each powder vial contains nominally 1000 IU turoctocog alfa pegol*. After reconstitution, 1 mL of solution contains approximately 250 IU

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS...Each powder vial contains nominally 1000 IU turoctocog alfa pegol*. After reconstitution, 1 mL of solution contains approximately 250 IU

Documents
TEST RAPORU - sanemprinting.comsanemprinting.com/pdf/reach_testi_sonuclari_turkce.pdfAntrasin ya lar ve antrasin macunlar (antrasin konsantrasyonu Analitik tespiti) Kömür Katran

TEST RAPORU - sanemprinting.comsanemprinting.com/pdf/reach_testi_sonuclari_turkce.pdfAntrasin ya lar ve antrasin macunlar (antrasin konsantrasyonu Analitik tespiti) Kömür Katran

Documents
HBeAg-positive patients with HBsAg < 100 IU/mL and

HBeAg-positive patients with HBsAg < 100 IU/mL and

Documents
Calcitonins containing medicinal products · Nasal spray solution Nasal use Spray container 2,78 ml (28 doses) 1 Calcitonin 50 von ct Amp. 50 IU/ml Solution for injection Subcutaneous

Calcitonins containing medicinal products · Nasal spray solution Nasal use Spray container 2,78 ml (28 doses) 1 Calcitonin 50 von ct Amp. 50 IU/ml Solution for injection Subcutaneous

Documents
BLA Clinical Review Memorandum - fda.gov · 9/14/2016 · Reviewer Name Anuja Rastogi, MD MHS Review Completion Date / Stamped Date September 14, 2016 ... IU/mL and ≥1.0 IU/mL 30

BLA Clinical Review Memorandum - fda.gov · 9/14/2016 · Reviewer Name Anuja Rastogi, MD MHS Review Completion Date / Stamped Date September 14, 2016 ... IU/mL and ≥1.0 IU/mL 30

Documents
EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION … · NAT, with an assigned potency based on qualitative assay results of 30, 902 IU/mL (4.49 Log 10 IU/mL), when reconstituted in

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION … · NAT, with an assigned potency based on qualitative assay results of 30, 902 IU/mL (4.49 Log 10 IU/mL), when reconstituted in

Documents
Thyroid Disease Management - WordPress.com · Thyroid Disease Spectrum 0 5 10 TSH, IU/mL Mild Thyroid Failure TSH >4.0 IU/mL, Free T 4 Normal Overt Hypothyroidism TSH >4.0 IU/mL,

Thyroid Disease Management - WordPress.com · Thyroid Disease Spectrum 0 5 10 TSH, IU/mL Mild Thyroid Failure TSH >4.0 IU/mL, Free T 4 Normal Overt Hypothyroidism TSH >4.0 IU/mL,

Documents
ANIMAL HEALTH PRODUCTS - bavet.com.tr€¦ · 100 mg/ml menbutone 25 mg/ml Polymerized silicone 500.000 IU/ml Vitamin A, 75.000 IU/ml Vitamin D3, 50 mg/ml Vitamin E 100 mg/ml Butaphosphan,

ANIMAL HEALTH PRODUCTS - bavet.com.tr€¦ · 100 mg/ml menbutone 25 mg/ml Polymerized silicone 500.000 IU/ml Vitamin A, 75.000 IU/ml Vitamin D3, 50 mg/ml Vitamin E 100 mg/ml Butaphosphan,

Documents
100 IU/ml - Sanofipk.sanofi-aventis.com/products/Lantus.pdf · 100 IU/ml (Insulin glargine) Composition Each ml of the solution for injection contains 100 IU of insulin glargine

100 IU/ml - Sanofipk.sanofi-aventis.com/products/Lantus.pdf · 100 IU/ml (Insulin glargine) Composition Each ml of the solution for injection contains 100 IU of insulin glargine

Documents
NDA 20-287/S-035 SPINAL/EPIDURAL HEMATOMAS€¦ · 10,000 IU were 0.19 ± 0.04, 0.41 ± 0.07 and 0.82 ± 0.10 IU/mL, respectively, and were attained in about 4 hours in most subjects

NDA 20-287/S-035 SPINAL/EPIDURAL HEMATOMAS€¦ · 10,000 IU were 0.19 ± 0.04, 0.41 ± 0.07 and 0.82 ± 0.10 IU/mL, respectively, and were attained in about 4 hours in most subjects

Documents
VETERINARY MEDICAMENTS PRODUCER - Bioveta · oxytocin bio 5 iu/ml 102 penbital 400 mg/ml 199 pix fagi 180 polyequan 184 rometar 20 mg/ml 149 streptonamid 114 top spot on stronger

VETERINARY MEDICAMENTS PRODUCER - Bioveta · oxytocin bio 5 iu/ml 102 penbital 400 mg/ml 199 pix fagi 180 polyequan 184 rometar 20 mg/ml 149 streptonamid 114 top spot on stronger

Documents
u Iu Iu Iu 111 SYNTHESIS, CHARACTERIZATION AND CATALYTIC

u Iu Iu Iu 111 SYNTHESIS, CHARACTERIZATION AND CATALYTIC

Documents
Treatment-experienced Patients in Central and Eastern ...regist2.virology-education.com/presentations/2018/4CEE/11_Aster.pdf · Apr 2018: 708 000 IU/ml May 2018: 197 000 IU/ml May

Treatment-experienced Patients in Central and Eastern ...regist2.virology-education.com/presentations/2018/4CEE/11_Aster.pdf · Apr 2018: 708 000 IU/ml May 2018: 197 000 IU/ml May

Documents
SPS · Web view8,000 IU (80 mg) in 0.8 mL 10,000 IU (100 mg) in 1 mL The products were compared with the originator enoxaparin product, Clexane4 (20, 40, 60, and 100mg strengths)

SPS · Web view8,000 IU (80 mg) in 0.8 mL 10,000 IU (100 mg) in 1 mL The products were compared with the originator enoxaparin product, Clexane4 (20, 40, 60, and 100mg strengths)

Documents
Virological assessment of patients candidate to DAAregist2.virology-education.com/2015/13EU/03_Svicher.pdf(log 1w 4w 5w 6w 1 2 3 4 5 6 7 LLOQ (12 IU/ml) HCV-RNA IU/ml) Non Responder

Virological assessment of patients candidate to DAAregist2.virology-education.com/2015/13EU/03_Svicher.pdf(log 1w 4w 5w 6w 1 2 3 4 5 6 7 LLOQ (12 IU/ml) HCV-RNA IU/ml) Non Responder

Documents
Hepatitis B serology Laboratory : Distribution : 4202 Page ... · Specimen 4140: 519 IU/mL (16-946) with Abbott Architect; 340 IU/mL (22-1000) with DiaSorin Liaison. Specimen 4142:

Hepatitis B serology Laboratory : Distribution : 4202 Page ... · Specimen 4140: 519 IU/mL (16-946) with Abbott Architect; 340 IU/mL (22-1000) with DiaSorin Liaison. Specimen 4142:

Documents
PRODUCT MONOGRAPH INTRON A - merck.ca · 18 million IU interferon alfa-2b/pen (15 million IU/mL) 30 million IU interferon alfa-2b/pen (25 million IU/mL) 60 million IU interferon alfa-2b/pen

PRODUCT MONOGRAPH INTRON A - merck.ca · 18 million IU interferon alfa-2b/pen (15 million IU/mL) 30 million IU interferon alfa-2b/pen (25 million IU/mL) 60 million IU interferon alfa-2b/pen

Documents
Accreditation Standard ISO 15189:2012 - AnandLab · Rate Nephlometry 50 IU/mL to 1600 IU/mL 5.1 36 CLINICAL BIOCHEM ISTRY Serum Pregnancy Associated Plasma Protein A (PAPPA) Trace

Accreditation Standard ISO 15189:2012 - AnandLab · Rate Nephlometry 50 IU/mL to 1600 IU/mL 5.1 36 CLINICAL BIOCHEM ISTRY Serum Pregnancy Associated Plasma Protein A (PAPPA) Trace

Documents
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · 1. NAME OF THE MEDICINAL PRODUCT . Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe . Binocrit 2,000 IU/1 mL solution

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · 1. NAME OF THE MEDICINAL PRODUCT . Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe . Binocrit 2,000 IU/1 mL solution

Documents
NEW ZEALAND DATA SHEET - MedsafeVersion: pfdfragi10219 Supersedes: pfdfragi10213 Page 1 of 20 NEW ZEALAND DATA SHEET 1. PRODUCT NAME FRAGMIN ® 10000 IU/mL, 12500 IU/mL, 25000 IU/mL

NEW ZEALAND DATA SHEET - MedsafeVersion: pfdfragi10219 Supersedes: pfdfragi10213 Page 1 of 20 NEW ZEALAND DATA SHEET 1. PRODUCT NAME FRAGMIN ® 10000 IU/mL, 12500 IU/mL, 25000 IU/mL

Documents
Biochi PmPic~a isothermal induction...solution (final concentration: 100 IU ml l penicillin, 0.1 mg ml-~ streptomycin, 0.25 txg ml ~ amphotericin B). Cells were counted in a haemocytometer,

Biochi PmPic~a isothermal induction...solution (final concentration: 100 IU ml l penicillin, 0.1 mg ml-~ streptomycin, 0.25 txg ml ~ amphotericin B). Cells were counted in a haemocytometer,

Documents
SUMMARY OF SAFETY AND EFFECTIVENESS … DNA copy template. ... concentrations are reported in IU/mL and log10 IU/mL. ... Report results as “HCV

SUMMARY OF SAFETY AND EFFECTIVENESS … DNA copy template. ... concentrations are reported in IU/mL and log10 IU/mL. ... Report results as “HCV

Documents
T-cellReceptor-optimizedPeptideSkewingoftheT-cell … · 2012-10-19 · 2.5% Cellkines (Helvetica Healthcare), 20 IU/ml IL-2, and 25 ng/ml IL-15 (both PeproTech). Throughout this

T-cellReceptor-optimizedPeptideSkewingoftheT-cell … · 2012-10-19 · 2.5% Cellkines (Helvetica Healthcare), 20 IU/ml IL-2, and 25 ng/ml IL-15 (both PeproTech). Throughout this

Documents
Bring Your DIABETES PRODUCTInsulin Injection R 40 Iu/Ml Insulin Aspart Regular Insulin Human, 30 Iu per Ml / Isophane Suspension 70 Iu per Ml Subcutaneous Doses of Insulin Glargine

Bring Your DIABETES PRODUCTInsulin Injection R 40 Iu/Ml Insulin Aspart Regular Insulin Human, 30 Iu per Ml / Isophane Suspension 70 Iu per Ml Subcutaneous Doses of Insulin Glargine

Documents
Case Report Hypereosinophilic syndrome with abundant ... · well as markedly elevated serum IL-5 (994 pg/mL), GM-CSF (456 pg/mL), and IgE (7056 IU/mL). No gene abnormalities of FIP1L1-PDGFRA,

Case Report Hypereosinophilic syndrome with abundant ... · well as markedly elevated serum IL-5 (994 pg/mL), GM-CSF (456 pg/mL), and IgE (7056 IU/mL). No gene abnormalities of FIP1L1-PDGFRA,

Documents
Supplementary Materials for...10% fetal calf serum (FCS; Biochrom), penicillin (100 IU/mL), streptomycin (100 µg/mL) and 4 mM glutamine. For virus production, cells were transfected

Supplementary Materials for...10% fetal calf serum (FCS; Biochrom), penicillin (100 IU/mL), streptomycin (100 µg/mL) and 4 mM glutamine. For virus production, cells were transfected

Documents
Reference ID: 3149182 · 2012-08-27 · quantitation of 25 IU per mL. SVR was defined as HCV RNA less than 25 IU per mL at last observation within the SVR visit window (i.e., weeks

Reference ID: 3149182 · 2012-08-27 · quantitation of 25 IU per mL. SVR was defined as HCV RNA less than 25 IU per mL at last observation within the SVR visit window (i.e., weeks

Documents